Search Within

Haley Frances Hauser

Formats
  1. Meeting Abstract (11)
  2. Journal Article (6)
  3. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (18)
  2. Department of Medicine (18)
  3. Gastrointestinal Oncology Service (18)
  4. Solid Tumor Oncology Division (18)
  5. Weinberg Fellows (13)
  6. Survivorship Research (11)

More Groups

People
  1. Diane Reidy (14)
  2. Nitya Raj (13)
  3. Tiffany Le (11)
  4. Joanne Chou (8)
  5. Marinela Capanu (6)
  6. Michael D'Angelica (6)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (7)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Pancreas (5)
  3. Annals of Surgery (1)
  4. Cancer Medicine (1)
  5. Clinical Genitourinary Cancer (1)
  6. Current Treatment Options in Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Lippincott Williams & Wilkins (6)
  3. American Medical Association (1)
  4. Bioscientifica Ltd (1)
  5. Elsevier Inc. (1)
  6. Springer (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early-onset pancreatic neuroendocrine tumors: Clinical presentation, pathology features, and oncological outcomes
    Journal Article

    Pulvirenti, A.; Hauser, H. F.; Fiedler, L. M.; McIntyre, C. A.; Le, T.; Reidy-Lagunes, D. L.; Soares, K. C.; Balachandran, V. P.; Kingham, T. P.; D'Angelica, M. I.; more...
    Annals of Surgery (2024)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms treated in the “modern era”: A multicenter retrospective review
    Journal Article

    Le, B. K.; McGarrah, P.; Paciorek, A.; Mohamed, A.; Apolo, A. B.; Chan, D. L.; Reidy-Lagunes, D.; Hauser, H.; Rivero, J. D.; Whitman, J.; more...
    Clinical Genitourinary Cancer (2023)

    Fulltext@MSK | Save
  • Early onset well-differentiated pancreatic neuroendocrine tumors: clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C.; Reidy-Lagunes, D.; Wei, A.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms (NENs) treated in the "modern era": A multicenter retrospective review
    Meeting Abstract

    Le, B. K.; McGarrah, P. W.; Whitman, J.; Paciorek, A.; Raj, N.; Reidy-Lagunes, D.; Hauser, H.; Le, T.; Del Rivero, J.; Apolo, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • A randomized trial evaluating patient experience and preference between octreotide long-acting release and lanreotide for treatment of well-differentiated neuroendocrine tumors
    Journal Article

    Raj, N.; Cruz, E.; O'Shaughnessy, S.; Calderon, C.; Chou, J. F.; Capanu, M.; Heffernan, O.; DeMore, A.; Punn, S.; Le, T.; more...
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Early-onset well differentiated pancreatic neuroendocrine tumors: Clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C. A.; Reidy, D. L.; Wei, A. C. C.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms treated with immune checkpoint inhibitors: A single-institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N. P.; Cruz, E.; Chou, J. F.; Capanu, M.; Heffernan, O.; Le, T.; Hauser, H.; Saltz, L. B.; Reidy, D. L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save